Xeris Biopharma Sets New Revenue Records and Projects More Than 30% Growth for 2026
Market Chameleon (Mon, 2-Mar 7:57 AM)
Xeris Projects Record 2025 Revenues, Driven by Strong Growth in Recorlev, Gvoke, and Keveyis
Market Chameleon (Thu, 8-Jan 8:41 AM)